Stay updated on Pembrolizumab for Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThe page shows a revision tag change from v3.6.3 to v3.6.4, indicating a minor update to metadata or formatting. It does not affect the study data or user-facing content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing Revision: v3.6.2. This indicates the page has been updated to a newer revision of the content and formatting.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page footer now displays Revision: v3.6.2 instead of Revision: v3.6.0, reflecting a minor platform update to the study page.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded a recruitment status notice 'No longer looking for participants' and introduced new user guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), improving clarity and navigation for study records. Replaced the label 'Intervention / Treatment' with 'Intervention/Treatment' and updated revision information by removing 'Revision: v3.5.5' and adding 'Revision: v3.6.0'.SummaryDifference0.5%

- Check56 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating an updated version of the record; the change appears to be administrative/version tracking rather than content changes to the clinical trial information.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new site build/version. This represents an internal update rather than a change to the visible study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.